Two medical researchers are working together. They are seated at a work station in a laboratory. The female scientist is using a pipette to measure a liquid sample. Her male colleague is assisting and watching carefully. A third scientist is visible in the background. Microbiome, Foundation, Sample Technologies

The host-associated microbiome interacts extensively with the host’s metabolism and immune system, playing a key role in health and function. Symbiosis and dysbiosis affects cancer, autoimmune disease, allergies, asthma and various metabolic disorders. Studying microbiome composition through metagenomic next-generation sequencing (NGS) is the key to discovering the influences of host-microbiome interactions. Unfortunately, microbial DNA may be a vanishingly small amount of the total DNA and is often eclipsed by host DNA in libraries. This leaves few reads for microbial genome analysis, leading toextremely high sequencing costs per useful read. And when resources are tight, every read counts. Thus, we have developed a protocol that depletes host DNA in tissue, swab and bodily fluids to a negligible amount. In this webinar, we will present this protocol, data and a new kit that depletes host-DNA to better target microbes and the microbiome.

In order to develop optimal workflows for NGS analysis of microbes and microbiomes, having a dedicated toolbox for the tasks at hand helps with achieving high sensitivity and finding the proverbial needle in the haystack. Dedicated tools include bioinformatic tools for depletion of host-derived reads, tools and databases for metagenomic analysis. Here, we will introduce the tools, show how to string them together in workflows and interactively explore results using the QIAGEN CLC Genomics Workbench.

About the speaker
Dominic O'Neil, M.S., M.B.A., Director, Microbiome Product Development
QIAGEN
Dominic O'Neil has over 20 years of experience in the biotechnology industry. Before joining QIAGEN, he gained molecular biology expertise at several companies, including three years at the Whitehead/MIT Center for Genome Research in Cambridge, MA, where he participated in the completion of the initial draft of the human genome. Dominic joined Digene (which later became part of QIAGEN) in 2004 to work on new technology research and development, focusing in particular on sample preparation and diagnostic applications. In 2011, he joined the QIAGEN R&D group in Hilden to work on solutions for next-generation sequencing. Starting in 2015, he focused on microbiome extraction and associated workflows and now leads the R&D group as Director for Microbiome Product Development.
Leif Schauser, PhD, Director Product Management Genome Analysis, Bioinformatics
QIAGEN
Leif Schauser holds a PhD in plant molecular genetics from Aarhus University, Denmark. He did his postdoctoral training in Norwich, UK, before working as a professor in bioinformatics at Aarhus University. In 2013 Leif joined CLC bio, just before its acquisition by QIAGEN. During his time at QIAGEN, Leif has worked with many aspects of bioinformatics, ranging from microbial genomics and metagenomics to biomedical applications.
Wednesday, June 25, 2025
01:00:00 PM (UTC) - 02:00:00 PM (UTC)
Duration:60 minutes
Categories
Online webinar
Microbiology
Microbiome
dPCR
Digital PCR
OSZAR »